FDA Drug Shortage Database
Dexmedetomidine (Precedex) shortage
The FDA Drug Shortage Database lists 11 of 59 dexmedetomidine presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on April 10, 2020. 45 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 1ml injection | 9 | 16 | 3 |
| 2ml injection | 0 | 1 | 0 |
| 4mcg/ml injection | 0 | 2 | 0 |
| 50ml injection | 1 | 2 | 0 |
| 80mcg/20ml injection | 0 | 3 | 0 |
| 100ml injection | 0 | 3 | 0 |
| 200mcg/2ml injection | 1 | 1 | 0 |
| 200mcg/50ml injection | 0 | 7 | 0 |
| 400mcg/100ml injection | 0 | 7 | 0 |
| 1000mcg/250ml injection | 0 | 3 | 0 |
Which presentations are listed?
Limited or unavailable now (11)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25) | Hikma Pharmaceuticals USA, Inc. | Current posted April 10, 2020, updated September 18, 2026 | Unavailable; Demand increase for the drug |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | Accord Healthcare Inc. | Current posted April 10, 2020, updated September 15, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93) | Accord Healthcare Inc. | Current posted April 10, 2020, updated September 15, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02) | Fresenius Kabi USA, LLC | Current posted April 10, 2020, updated October 6, 2026 | Unavailable; Demand increase for the drug |
| Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | Current posted April 10, 2020, updated October 5, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24) | Baxter Healthcare | Current posted April 10, 2020, updated August 17, 2026 | Unavailable; Other |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20) | Par Health, USA LLC | Current posted April 10, 2020, updated October 2, 2026 | Unavailable; Other |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10) | Par Health, USA LLC | Current posted April 10, 2020, updated October 2, 2026 | Unavailable; Other |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00) | Fresenius Kabi USA, LLC | Current posted April 10, 2020, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20) | Fresenius Kabi USA, LLC | Current posted April 10, 2020, updated October 6, 2026 | Unavailable; Other |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50) | Fresenius Kabi USA, LLC | Current posted April 10, 2020, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
Listed now, available (45)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25) | Par Health, USA LLC | Current posted April 10, 2020, updated August 18, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04) | HQ Specialty Pharma | Current posted April 10, 2020, updated October 1, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04) | HQ Specialty Pharma | Current posted April 10, 2020, updated October 1, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02) | Eugia US LLC | Current posted April 10, 2020, updated October 2, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) | Mylan Institutional, a Viatris Company | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04) | Somerset Therapeutics, LLC | Current posted April 10, 2020, updated September 11, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04) | Somerset Therapeutics, LLC | Current posted April 10, 2020, updated September 11, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03) | Meitheal Pharmaceuticals, Inc. | Current posted April 10, 2021, updated August 27, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10) | Azurity Pharmaceuticals, Inc | Current posted April 10, 2020, updated September 16, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10) | Azurity Pharmaceuticals, Inc | Current posted April 10, 2020, updated September 16, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42) | Gland Pharma Limited | Current posted April 10, 2020, updated July 22, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24) | Baxter Healthcare | Current posted April 10, 2020, updated October 2, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50) | Mylan Institutional, a Viatris Company | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1) | Amneal Pharmaceuticals | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1) | Amneal Pharmaceuticals | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58) | Gland Pharma Limited | Current posted April 10, 2020, updated July 22, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58) | Gland Pharma Limited | Current posted April 10, 2020, updated July 22, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) | HQ Specialty Pharma | Current posted April 10, 2020, updated October 1, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) | HQ Specialty Pharma | Current posted April 10, 2020, updated October 1, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10) | Eugia US LLC | Current posted April 10, 2020, updated October 2, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10) | Eugia US LLC | Current posted April 10, 2020, updated October 2, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8) | Amneal Pharmaceuticals | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7) | Amneal Pharmaceuticals | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08) | Azurity Pharmaceuticals, Inc | Current posted April 10, 2020, updated September 16, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08) | Azurity Pharmaceuticals, Inc | Current posted April 10, 2020, updated September 16, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12) | Baxter Healthcare | Current posted April 10, 2020, updated October 2, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12) | Baxter Healthcare | Current posted April 10, 2020, updated October 2, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10) | Mylan Institutional, a Viatris Company | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Current posted April 10, 2020, updated October 5, 2026 | Available |
| Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02) | Pfizer Inc. | Current posted April 10, 2020, updated September 8, 2026 | Available |
| Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10) | Pfizer Inc. | Current posted April 10, 2020, updated August 24, 2026 | Available |
| Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) | Pfizer Inc. | Current posted April 10, 2020, updated September 21, 2026 | Available |
| Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10) | Pfizer Inc. | Current posted April 10, 2020, updated September 8, 2026 | Available |
Resolved or discontinued (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | Accord Healthcare Inc. | To Be Discontinued posted April 21, 2026, updated April 21, 2026 | not given |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05) | Slayback Pharma | To Be Discontinued posted June 5, 2026, updated June 5, 2026 | not given |
| Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06) | Slayback Pharma | To Be Discontinued posted June 5, 2026, updated June 5, 2026 | not given |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage